2011
DOI: 10.3851/imp1808
|View full text |Cite
|
Sign up to set email alerts
|

Argonaute-2 Enhances Suppression of Human Cytomegalovirus Replication by Polycistronic Short Hairpin Rnas Targeting Ul46, Ul70 and Ul122

Abstract: Coexpression of Ago2 with shRNA-miRs enhanced the production of mature siRNAs and increased the efficiency of RNA silencing in the suppression of HCMV replication. This strategy may be universally applied to RNA interference-based therapies.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2013
2013
2023
2023

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(2 citation statements)
references
References 47 publications
0
2
0
Order By: Relevance
“…Unlike in the situation where AGO proteins are overexpressed, in the situation where AGO proteins are limiting and the RISCs are already occupied with cellular miRNAs, de novo-synthesized mivaRNAs are likely to become less readily incorporated into RISCs. In analogy, overexpression of AGO2 has been demonstrated to abrogate saturation of RISCs, consequently facilitating RISC incorporation of exogenous siRNAs or shRNAs by abolishing the competition with cellular miRNAs (41)(42)(43)(44). Thus, our data indicate that RISC occupation by mivaRNAs appears to have been overestimated in the past, because under physiologically more relevant conditions, cellular miRNAs are still dominating over mivaRNAs in endogenous RISCs.…”
Section: Discussionmentioning
confidence: 60%
“…Unlike in the situation where AGO proteins are overexpressed, in the situation where AGO proteins are limiting and the RISCs are already occupied with cellular miRNAs, de novo-synthesized mivaRNAs are likely to become less readily incorporated into RISCs. In analogy, overexpression of AGO2 has been demonstrated to abrogate saturation of RISCs, consequently facilitating RISC incorporation of exogenous siRNAs or shRNAs by abolishing the competition with cellular miRNAs (41)(42)(43)(44). Thus, our data indicate that RISC occupation by mivaRNAs appears to have been overestimated in the past, because under physiologically more relevant conditions, cellular miRNAs are still dominating over mivaRNAs in endogenous RISCs.…”
Section: Discussionmentioning
confidence: 60%
“…As demonstrated, these three methodological avenues can enhance the potency of all conventional RNAi triggers—transfected si or shRNAs or transduced shRNAs—in mammalian cells ex or in vivo . While previous reports had already indicated that ectopic Ago2 expression can enhance si or shRNA activity ( 16 , 17 , 60 , 61 ), the present work represents an important advance in our understanding of Ago2/RNAi biology and its implications for RNAi applications, for three reasons: First, the comprehensive and systematic evaluation of the benefits of Ago2 overexpression in cell lines, primary cells and animals underscores the enormous potential to improve a wide range of typical small- and large-scale RNAi experiments, including high-content screens. Second, the alleviation of shRNA-induced in vivo hepatotoxicities with Ago2-co-encoding vectors reaffirms prior models that a major hurdle for therapeutic RNAi is saturation of the cellular pathway with ecoptic triggers, and concurrently provides a new solution.…”
Section: Discussionmentioning
confidence: 96%